We are live on ! Find out more
ACER

Acer Therapeutics Inc

Delisted

ACER was delisted on the 8th of November, 2023.

14 hedge funds and large institutions have $893K invested in Acer Therapeutics Inc in 2013 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

129% more capital invested

Capital invested by funds: $389K → $893K (+$504K)

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

17% more funds holding

Funds holding: 1214 (+2)

Holders
14
Holders Change
+2
Holders Change %
+16.67%
% of All Funds
0.45%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
3
Reduced
1
Closed
3
Calls
Puts
Net Calls
Net Calls Change

ACER Hedge Fund Activity: Q3 2013 in Review

14 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q3 2013, worth a combined $893K — up 129% from $389K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new ACER positions and 3 closed out — a net gain of 3 holders — while 3 added to existing stakes and 1 trimmed.

The largest buyer was California Public Employees Retirement System, adding an estimated $120K. The largest seller was Goldman Sachs, exiting entirely with an estimated $19K sold.

  • 14 institutional investors held Acer Therapeutics Inc (ACER) as of Q3 2013, up from 12 in Q2 2013.
  • Funds reported $893K of Acer Therapeutics Inc stock for Q3 2013, up 129% quarter-over-quarter.
  • 6 funds opened new Acer Therapeutics Inc positions in Q3 2013 and 3 closed out, a net change of +3 holders.
  • The largest Acer Therapeutics Inc buyer in Q3 2013 was California Public Employees Retirement System, an estimated $120K added.
  • The largest Acer Therapeutics Inc seller in Q3 2013 was Goldman Sachs, an estimated $19K sold.

Based on aggregated 13F filings for Q3 2013.